Analyst Price Targets — PGNY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 9:52 am | — | KeyBanc | $35.00 | $30.65 | TheFly | Progyny price target raised to $35 from $30 at KeyBanc |
| May 19, 2026 8:43 am | — | Canaccord Genuity | $30.00 | $24.05 | TheFly | Progyny upgraded to Buy from Hold at Canaccord |
| May 15, 2026 6:56 pm | — | Barclays | $27.00 | $23.25 | TheFly | Progyny price target raised to $27 from $23 at Barclays |
| March 6, 2026 5:01 pm | Brian Tanquilut | Jefferies | $30.00 | $17.79 | StreetInsider | Progyny (PGNY) PT Lowered to $30 at Jefferies |
| March 2, 2026 10:24 am | Jailendra Singh | Truist Financial | $28.00 | $17.69 | StreetInsider | Progyny (PGNY) PT Lowered to $28 at Truist Securities |
| January 21, 2026 12:17 pm | — | J.P. Morgan | $35.00 | $25.28 | TheFly | Progyny price target raised to $35 from $30 at BTIG |
| January 8, 2026 2:24 pm | Jailendra Singh | Truist Financial | $34.00 | $28.23 | TheFly | Progyny upgraded to Buy from Hold at Truist |
| January 8, 2026 12:44 pm | Scott Schoenhaus | KeyBanc | $32.00 | $26.80 | TheFly | Progyny price target raised to $32 from $30 at KeyBanc |
| December 8, 2025 9:16 pm | Peter Warendorf | Barclays | $29.00 | $24.70 | TheFly | Progyny initiated with an Overweight at Barclays |
| November 11, 2025 9:42 pm | — | KeyBanc | $30.00 | $23.81 | TheFly | KeyBanc upgrades Progyny to Overweight on 'emerging' catalysts |
Latest News for PGNY
JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions and solid fundamentals amid market uncertainty.
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PGNY.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.